NCT04237246View on ClinicalTrials.gov

Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver Transplants

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 27, 2019

Study Completion Date

November 27, 2019

Conditions
Liver Failure
Interventions
DRUG

Tacrolimus

"24 hour long acting advegraf"

Trial Locations (1)

R2K0a2

John Buhler Research Centre Health Sciences Centre, Winnipeg

All Listed Sponsors
lead

University of Manitoba

OTHER

NCT04237246 - Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver Transplants | Biotech Hunter | Biotech Hunter